Dow Up1.31% Nasdaq Up2.40%

Acura Pharmaceuticals, Inc. (ACUR)

-NasdaqCM
0.59 0.01(1.74%) Oct 21, 3:59PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue 35   42   35   83  
Cost of Revenue42  38  36  78  
Gross Profit (7) 4   (1) 5  
Operating Expenses
Research Development1,281  1,438  803  1,289  
Selling General and Administrative1,916  2,259  2,427  2,302  
Non Recurring68  133  250  (361)
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (3,272) (3,826) (3,481) (3,225)
Income from Continuing Operations
Total Other Income/Expenses Net53  39  73  35  
Earnings Before Interest And Taxes(3,219)(3,787)(3,408)(3,190)
Interest Expense302  301  9   -  
Income Before Tax(3,521)(4,088)(3,417)(3,190)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(3,521)(4,088)(3,417)(3,190)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (3,521) (4,088) (3,417) (3,190)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (3,521) (4,088) (3,417) (3,190)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.